UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | C | D | F | G | H | J | K | L | M | N | O | P | R | S | T | U | V | W | Y
Number of items: 76.

B

Bejugam, M; Gunaratnam, M; Müller, S; Sanders, DA; Sewitz, S; Fletcher, JA; Neidle, S; (2010) Targeting the c-Kit Promoter G-quadruplexes with 6-Substituted Indenoisoquinolines. ACS Med Chem Lett , 1 (7) pp. 306-310. 10.1021/ml100062z.

Bilanges, B; Vanhaesebroeck, B; (2010) A new tool to dissect the function of p70 S6 kinase. Biochem J , 431 (2) e1-e3. 10.1042/BJ20101445.

Boss, DS; Schwartz, GK; Middleton, MR; Amakye, DD; Swaisland, H; Midgley, RS; Ranson, M; (2010) Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours. ANN ONCOL , 21 (4) 884 - 894. 10.1093/annonc/mdp377.

Brada, M; Stenning, S; Gabe, R; Thompson, LC; Levy, D; Rampling, R; Erridge, S; (2010) Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma. JOURNAL OF CLINICAL ONCOLOGY , 28 (30) 4601 - 4608. 10.1200/JCO.2009.27.1932.

Brunetto, AT; Kristeleit, RS; de Bono, JS; (2010) Early oncology clinical trial design in the era of molecular-targeted agents. Future Oncol , 6 (8) pp. 1339-1352. 10.2217/fon.10.92.

Brunetto, AT; Sarker, D; Papadatos-Pastos, D; Fehrmann, R; Kaye, SB; Johnston, S; Allen, M; (2010) A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit. Br J Cancer , 103 (5) pp. 607-612. 10.1038/sj.bjc.6605812.

C

Cain, RJ; Vanhaesebroeck, B; Ridley, AJ; (2010) The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol , 188 (6) pp. 863-876. 10.1083/jcb.200907135.

Chavda, S; Babu, B; Yanow, SK; Jardim, A; Spithill, TW; Kiakos, K; Kluza, J; (2010) A novel achiral seco-cyclopropylpyrido[e]indolone (CPyI) analog of CC-1065 and the duocarmycins: Synthesis, DNA interactions, in vivo anticancer and anti-parasitic evaluation. BIOORGAN MED CHEM , 18 (14) 5016 - 5024. 10.1016/j.bmc.2010.05.078.

Chavda, S; Mulder, K; Brown, T; Mackay, H; Babu, B; Westrate, L; Ferguson, A; (2010) DNA Recognition: Design, Synthesis and Biophysical Characteristics of Pyrrole(H) Based Polyamides. MED CHEM , 6 (3) 150 - 158.

D

Dhami, P; Bruce, AW; Jim, JH; Dillon, SC; Hall, A; Cooper, JL; Bonhoure, N; (2010) Genomic Approaches Uncover Increasing Complexities in the Regulatory Landscape at the Human SCL (TAL1) Locus. PLOS ONE , 5 (2) , Article e9059. 10.1371/journal.pone.0009059. Green open access
file

Dhami, P; Saffrey, P; Bruce, AW; Dillon, SC; Chiang, K; Bonhoure, N; Koch, CM; (2010) Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution. PLOS ONE , 5 (8) , Article e12339. 10.1371/journal.pone.0012339. Green open access
file

Dick, J; Begent, RH; Meyer, T; (2010) Sarcoidosis and testicular cancer: A case series and literature review. UROL ONCOL-SEMIN ORI , 28 (4) 350 - 354. 10.1016/j.urolonc.2008.09.029.

F

Fenton, TR; Gwalter, J; Cramer, R; Gout, IT; (2010) S6K1 is acetylated at lysine 516 in response to growth factor stimulation. BIOCHEM BIOPH RES CO , 398 (3) 400 - 405. 10.1016/j.bbrc.2010.06.081.

Fenton, TR; Gwalter, J; Ericsson, J; Gout, IT; (2010) Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo. INT J BIOCHEM CELL B , 42 (2) 359 - 366. 10.1016/j.biocel.2009.11.022.

Fischer, U; Leidinger, P; Keller, A; Folarin, A; Keller, R; Graf, N; Lenhof, HP; (2010) Amplicons on chromosome 12q13-21 in glioblastoma recurrences. INT J CANCER , 126 (11) 2594 - 2602. 10.1002/ijc.24971.

Fish, R; Pinney, J; Jain, P; Addison, C; Jones, C; Jayawardene, S; Booth, J; (2010) The Incidence of Major Hemorrhagic Complications After Renal Biopsies in Patients with Monoclonal Gammopathies. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , 5 (11) pp. 1977-1980.

Folarin, AA; Konerding, MA; Timonen, J; Nagl, S; Pedley, RB; (2010) Three-dimensional analysis of tumour vascular corrosion casts using stereoimaging and micro-computed tomography. MICROVASC RES , 80 (1) 89 - 98. 10.1016/j.mvr.2010.03.007.

Forster, M; Enting, D; Nicholson, AG; O'Brien, M; Popat, S; (2010) The combination of Young's syndrome and small cell lung cancer-A spiky connection? Lung Cancer , 67 (3) pp. 372-375. 10.1016/j.lungcan.2009.10.011.

Forster, MD; Saijo, N; Seymour, L; Calvert, H; (2010) Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan. CLIN CANCER RES , 16 (6) 1737 - 1744. 10.1158/1078-0432.CCR-09-2228.

Foukas, LC; Berenjeno, IM; Gray, A; Khwaja, A; Vanhaesebroeck, B; (2010) Activity of any class IA PI3K isoform can sustain cell proliferation and survival. P NATL ACAD SCI USA , 107 (25) 11381 - 11386. 10.1073/pnas.0906461107.

Franks, A; Tronrud, C; Kiakos, K; Kluza, J; Munde, M; Brown, T; Mackay, H; (2010) Targeting the ICB2 site of the topoisomerase II alpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamide. BIOORGAN MED CHEM , 18 (15) 5553 - 5561. 10.1016/j.bmc.2010.06.041.

G

Germani, G; Pleguezuelo, M; Gurusamy, K; Meyer, T; Isgro, G; Burroughs, AK; (2010) Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. J HEPATOL , 52 (3) 380 - 388.

Giampieri, S; Pinner, S; Sahai, E; (2010) Intravital Imaging Illuminates Transforming Growth Factor beta Signaling Switches during Metastasis. CANCER RESEARCH , 70 (9) pp. 3435-3439. 10.1158/0008-5472.CAN-10-0466.

Gillmore, R; Laurence, V; Raouf, S; Tobias, J; Blackman, G; Meyer, T; Goodchild, K; (2010) Chemoradiotherapy with or without Induction Chemotherapy for Locally Advanced Pancreatic Cancer: a UK Multi-institutional Experience. CLIN ONCOL-UK , 22 (7) 564 - 569. 10.1016/j.clon.2010.05.007.

H

Hampel, SM; Sidibe, A; Gunaratnam, M; Riou, JF; Neidle, S; (2010) Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells. Bioorg Med Chem Lett , 20 (22) pp. 6459-6463. 10.1016/j.bmcl.2010.09.066.

Hartley, JA; Hamaguchi, A; Coffils, M; Martin, CRH; Suggitt, M; Chen, ZZ; Gregson, SJ; (2010) SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity. CANCER RES , 70 (17) 6849 - 6858. 10.1158/0008-5472.CAN-10-0790.

Hua, J; Spee, C; Kase, S; Rennel, ES; Magnussen, AL; Qiu, Y; Varey, A; (2010) Recombinant Human VEGF(165)b Inhibits Experimental Choroidal Neovascularization. INVEST OPHTH VIS SCI , 51 (8) 4282 - 4288. 10.1167/iovs.09-4360.

J

Juul, N; Szallasi, Z; Eklund, AC; Li, Q; Burrell, RA; Gerlinger, M; Valero, V; (2010) Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials. Lancet Oncol , 11 (4) pp. 358-365. 10.1016/S1470-2045(10)70018-8.

jones, A; lechner, M; fourkala, E; Kristeleit, R; Widschwendter, M; (2010) Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers. Epigenomics , 2 (1) 9 - 38.

K

Kiakos, K; Hartley, JM; Hartley, JA; (2010) Measurement of DNA interstrand crosslinking in naked DNA using gel-based methods. Methods Mol Biol , 613 pp. 283-302. 10.1007/978-1-60327-418-0_18.

Kuehn, HS; Rådinger, M; Brown, JM; Ali, K; Vanhaesebroeck, B; Beaven, MA; Metcalfe, DD; (2010) Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells. J Cell Sci , 123 (Pt 15) pp. 2576-2585. 10.1242/jcs.071043.

L

Ledermann, JA; Gabra, H; Jayson, GC; Spanswick, VJ; Rustin, GJS; Jitlal, M; James, LE; (2010) Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer. CLIN CANCER RES , 16 (19) 4899 - 4905. 10.1158/1078-0432.CCR-10-0832.

Ledermann, JA; Kristeleit, RS; (2010) Optimal treatment for relapsing ovarian cancer. ANN ONCOL , 21 218 - 222. 10.1093/annonc/mdq377.

Ledermann, JA; Raja, FA; (2010) Targeted trials in ovarian cancer. GYNECOL ONCOL , 119 (1) 151 - 156. 10.1016/j.ygyno.2010.05.008.

Lee, SM; Edwards, SG; Chilton, DN; Ramsay, A; Miller, RF; (2010) Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multicentric Castleman's disease. HAEMATOL-HEMATOL J , 95 (11) 1979 - 1981. 10.3324/haematol.2010.027441. Gold open access

Li, Q; Eklund, AC; Juul, N; Haibe-Kains, B; Workman, CT; Richardson, AL; Szallasi, Z; (2010) Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status. PLoS One , 5 (12) , Article e15031. 10.1371/journal.pone.0015031.

Low, PC; Misaki, R; Schroder, K; Stanley, AC; Sweet, MJ; Teasdale, RD; Vanhaesebroeck, B; (2010) Phosphoinositide 3-kinase δ regulates membrane fission of Golgi carriers for selective cytokine secretion. J Cell Biol , 190 (6) pp. 1053-1065. 10.1083/jcb.201001028.

M

Magnussen, AL; Rennel, ES; Hua, J; Bevan, HS; Long, NB; Lehrling, C; Gammons, M; (2010) VEGF-A(165)b Is Cytoprotective and Antiangiogenic in the Retina. INVEST OPHTH VIS SCI , 51 (8) 4273 - 4281. 10.1167/iovs.09-4296.

Martin, V; Guillermet-Guibert, J; Chicanne, G; Cabou, C; Jandrot-Perrus, M; Plantavid, M; Vanhaesebroeck, B; (2010) Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood , 115 (10) pp. 2008-2013. 10.1182/blood-2009-04-217224.

Matthews, DR; Carlin, LM; Ofo, E; Barber, PR; Vojnovic, B; Irving, M; Ng, T; (2010) Time-lapse FRET microscopy using fluorescence anisotropy. J Microsc , 237 (1) pp. 51-62. 10.1111/j.1365-2818.2009.03301.x.

McKeen, HD; Byrne, C; Jithesh, PV; Donley, C; Valentine, A; Yakkundi, A; O'Rourke, M; (2010) FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy. Cancer Res , 70 (3) pp. 1090-1100. 10.1158/0008-5472.CAN-09-2515.

Meyer, T; Caplin, ME; Palmer, DH; Valle, JW; Larvin, M; Waters, JS; Coxon, F; (2010) A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. EUR J CANCER , 46 (3) 526 - 533. 10.1016/j.ejca.2009.11.004.

Meyer, T; Roughton, M; Yu, D; Davies, N; Williams, E; Pereira, SP; Hochhauser, D; (2010) A randomized phase II/III trial of three weekly cisplatin based transarterial chemoembolization (TACE) versus embolization (TAE) alone for hepatocellular cancer (HCC). JOURNAL OF CLINICAL ONCOLOGY , 28 (15)

Middleton, MR; Knox, R; Cattell, E; Oppermann, U; Midgley, R; Ali, R; Auton, T; (2010) Quinone Oxidoreductase-2-Mediated Prodrug Cancer Therapy. SCI TRANSL MED , 2 (40) , Article 40ra50. 10.1126/scitranslmed.3000615.

Molife, LR; Fong, PC; Paccagnella, L; Reid, AH; Shaw, HM; Vidal, L; Arkenau, HT; (2010) The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study. Br J Cancer , 103 (3) pp. 332-339. 10.1038/sj.bjc.6605767.

Munding, J; Baraniskin, A; Meier, D; Porschen, R; Arkenau, H; Graeven, U; Schulmann, K; (2010) Value of SMAD4 in patients with advanced colorectal cancer (aCRC) receiving an oxaliplatin containing first line chemotherapy - a study of the AIO colorectal cancer group (AIO). ONKOLOGIE , 33 71 - 72.

N

Nutt, JE; Razak, ARA; O'Toole, K; Black, F; Quinn, AE; Calvert, AH; Plummer, ER; (2010) The role of folate receptor alpha (FR alpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy. BRIT J CANCER , 102 (3) 553 - 560. 10.1038/sj.bjc.6605501.

O

Oliveira, JP; Fogo, AB; Bostad, L; Svarstad, E; Cook, WJ; Moll, S; Barbey, F; (2010) SCORING SYSTEM FOR RENAL PATHOLOGY IN FABRY DISEASE: REPORT OF THE INTERNATIONAL STUDY GROUP OF FABRY NEPHROPATHY (ISGFN). In: (Proceedings) 10th Annual European Round Table on Fabry Disease. (pp. S105-S105). ELSEVIER

Orikawa, Y; Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Hamano, H; Hori, Y; (2010) Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 beta production in a cancer-induced pain model in mice. MOL PAIN , 6 , Article 72. 10.1186/1744-8069-6-72. Gold open access

P

Patkar, V; Acosta, D; Fox, J; Jones, A; Davidson, T; Keshtgar, M; (2010) A novel support tool for Breast Multidisciplinary Meetings: an advanced evidence based computer decision support technology. In: EJC SUPPLEMENTS. (pp. 211 - 211). PERGAMON-ELSEVIER SCIENCE LTD

R

Ramadani, F; Bolland, DJ; Garcon, F; Emery, JL; Vanhaesebroeck, B; Corcoran, AE; Okkenhaug, K; (2010) The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci Signal , 3 (134) ra60-. 10.1126/scisignal.2001104.

Reichold, M; Zdebik, AA; Lieberer, E; Rapedius, M; Schmidt, K; Bandulik, S; Sterner, C; (2010) KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. P NATL ACAD SCI USA , 107 (32) 14490 - 14495. 10.1073/pnas.1003072107.

Rodriguez-Acebes, S; Proctor, I; Loddo, M; Wollenschlaeger, A; Rashid, M; Falzon, M; Prevost, AT; (2010) Targeting DNA Replication before it Starts Cdc7 as a Therapeutic Target in p53-Mutant Breast Cancers. AM J PATHOL , 177 (4) 2034 - 2045. 10.2353/ajpath.2010.100421.

S

Spanswick, VJ; Hartley, JM; Hartley, JA; (2010) Measurement of DNA interstrand crosslinking in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 613 pp. 267-282. 10.1007/978-1-60327-418-0_17.

Sparapani, S; Bellini, S; Gunaratnam, M; Haider, SM; Andreani, A; Rambaldi, M; Locatelli, A; (2010) Bis-guanylhydrazone diimidazo[1,2-a:1,2-c]pyrimidine as a novel and specific G-quadruplex binding motif. Chem Commun (Camb) , 46 (31) pp. 5680-5682. 10.1039/c0cc00020e.

Sparapani, S; Haider, SM; Doria, F; Gunaratnam, M; Neidle, S; (2010) Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes. J Am Chem Soc , 132 (35) pp. 12263-12272. 10.1021/ja1003944.

Srirajaskanthan, R; Caplin, ME; Waugh, MG; Watkins, J; Meyer, T; Hsuan, JJ; Beaumont, NJ; (2010) Identification of Mac-2-binding Protein as a Putative Marker of Neuroendocrine Tumors from the Analysis of Cell Line Secretomes. MOL CELL PROTEOMICS , 9 (4) 656 - 666. 10.1074/mcp.M900401-MCP200.

Strauss, SJ; Ng, T; Mendoza-Naranjo, A; Whelan, J; Sorensen, PHB; (2010) Understanding Micrometastatic Disease and Anoikis Resistance in Ewing Family of Tumors and Osteosarcoma. ONCOLOGIST , 15 (6) 627 - 635. 10.1634/theoncologist.2010-0093.

T

Taylor, RM; Franck, LS; Dhawan, A; Gibson, F; (2010) The Stories of Young People Living With a Liver Transplant. QUAL HEALTH RES , 20 (8) 1076 - 1090. 10.1177/1049732310368405.

Taylor, RM; Wray, J; Gibson, F; (2010) Measuring quality of life in children and young people after transplantation: Methodological considerations. PEDIATR TRANSPLANT , 14 (4) 445 - 458. 10.1111/j.1399-3046.2010.01316.x.

Thirlwell, C; Eymard, M; Feber, A; Teschendorff, A; Pearce, K; Lechner, M; Widschwendter, M; (2010) Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. METHODS , 52 (3) 248 - 254. 10.1016/j.ymeth.2010.04.012.

Thirlwell, C; Will, OCC; Domingo, E; Graham, TA; McDonald, SAC; Oukrif, D; Jeffrey, R; (2010) Clonality Assessment and Clonal Ordering of Individual Neoplastic Crypts Shows Polyclonality of Colorectal Adenomas. GASTROENTEROLOGY , 138 (4) 1441 - U298. 10.1053/j.gastro.2010.01.033.

Tobias, J; Hochhauser, D; (2010) Cancer and Its Management. Wiley-Blackwell

Tsochatzis, E; Garcovich, M; Marelli, L; Fede, G; Germani, G; Manousou, P; Arvaniti, V; (2010) TRANSARTERIAL CHEMOEMBOLIZATION AS NEO-ADJUVANT THERAPY PRE-TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA. In: (Proceedings) 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 858A-859A). WILEY-BLACKWELL

Tsochatzis, E; Meyer, T; Marelli, L; Burroughs, AK; (2010) Which transarterial therapy is best for hepatocellular carcinoma? - The evidence to date. J HEPATOL , 53 (3) 588 - 588.

Turner, NC; Strauss, SJ; Sarker, D; Gillmore, R; Kirkwood, A; Hackshaw, A; Papadopoulou, A; (2010) Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. BRIT J CANCER , 102 (7) 1106 - 1112. 10.1038/sj.bjc.6605618.

U

Uno, JK; Rao, KN; Matsuoka, K; Sheikh, SZ; Kobayashi, T; Li, F; Steinbach, EC; (2010) Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110δ. Gastroenterology , 139 (5) 1642-1653.e6. 10.1053/j.gastro.2010.07.008.

V

Valle, J; Wasan, H; Palmer, DH; Cunningham, D; Anthoney, A; Maraveyas, A; Madhusudan, S; (2010) Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer. NEW ENGL J MED , 362 (14) 1273 - 1281.

Vanhaesebroeck, B; Guillermet-Guibert, J; Graupera, M; Bilanges, B; (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol , 11 (5) pp. 329-341. 10.1038/nrm2882.

Vanhaesebroeck, B; Vogt, PK; Rommel, C; (2010) PI3K: From the bench to the clinic and back. Current Topics in Microbiology and Immunology , 347 (1) 1 - 19. 10.1007/82-2010-65.

Vanhaesebroeck, B; Vogt, PK; Rommel, C; (2010) PI3K: from the bench to the clinic and back. Curr Top Microbiol Immunol , 347 pp. 1-19. 10.1007/82_2010_65.

Vigor, KL; Kyrtatos, PG; Minogue, S; Al-Jamal, KT; Kogelberg, H; Tolner, B; Kostarelos, K; (2010) Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. BIOMATERIALS , 31 (6) 1307 - 1315. 10.1016/j.biomaterials.2009.10.036.

W

Walker, RJE; Toumpanakis, C; Marelli, L; Yu, D; Davies, N; Woodward, N; Goode, A; (2010) Transarterial embolization/chemoebolization for hepatic NET metastases: recent efficacy and toxicity data. In: (Proceedings) 18th International Symposium on Regulatory Peptides. (pp. p. 6). ELSEVIER SCIENCE BV

Wheatley-Price, P; Blackhall, F; Lee, S-M; Ma, C; Ashcroft, L; Jitlal, M; Qian, W; (2010) The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials. In: (pp. pp. 2023-2028). OXFORD UNIV PRESS

Y

Yap, TA; Vidal, L; Adam, J; Stephens, P; Spicer, J; Shaw, H; Ang, J; (2010) Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors. J CLIN ONCOL , 28 (25) 3965 - 3972. 10.1200/JCO.2009.26.7278.

Yong, M; Begent, R; (2010) Best use of experimental data in cancer informatics. Future Oncol , 6 (10) pp. 1551-1562. 10.2217/fon.10.108.

This list was generated on Sun Dec 4 03:35:20 2016 GMT.